BELITE BIO, INC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.97 USD | +6.10% |
|
+6.94% | -1.70% |
| 14/05 | Transcript : Belite Bio, Inc, Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | Belite Bio, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 131.09Cr | - | - | - | - | - | |
| 4.21TCr | ||||||
| 4.2TCr | ||||||
| 2.92TCr | ||||||
| 2.6TCr | ||||||
| 1.89TCr | - |
- Stock Market
- Equities
- BLTE Stock
- Charts Belite Bio, Inc
- Sector Chart
